{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:49:22Z","timestamp":1788536962732,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sechenov University Grant","award":["Project 5-100"],"award-info":[{"award-number":["Project 5-100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11306-020-01694-y","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T08:02:47Z","timestamp":1592380967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score"],"prefix":"10.1007","volume":"16","author":[{"given":"Pavel A.","family":"Markin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Moskaleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V.","family":"Lartsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeny V.","family":"Shpot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia V.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily Y.","family":"Mikhajlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Potoldykova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitry V.","family":"Enikeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"La Frano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9032-1558","authenticated-orcid":false,"given":"Svetlana A.","family":"Appolonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"issue":"6","key":"1694_CR1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","volume":"6","author":"F Baenke","year":"2013","unstructured":"Baenke, F., Peck, B., Miess, H., & Schulze, A. (2013). Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Disease Models & Mechanisms,6(6), 1353\u20131363.","journal-title":"Disease Models & Mechanisms"},{"issue":"6","key":"1694_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA a Cancer Journal for Clinicians,68(6), 394\u2013424.","journal-title":"CA a Cancer Journal for Clinicians"},{"issue":"2","key":"1694_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/cancers11020257","volume":"11","author":"R Bok","year":"2019","unstructured":"Bok, R., Lee, J., Sriram, R., Keshari, K., Sukumar, S., Daneshmandi, S., et al. (2019). The role of lactate metabolism in prostate cancer progression and metastases revealed by dual-agent hyperpolarized 13C MRSI. Cancers,11(2), 257.","journal-title":"Cancers"},{"key":"1694_CR4","volume-title":"TNM classification of malignant tumours","year":"2016","unstructured":"Brierley, J. D., Gospodarowicz, M. K., & Wittekind, C. (Eds.). (2016). TNM classification of malignant tumours. Hoboken: Wiley."},{"issue":"9","key":"1694_CR6","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-08-4289","volume":"69","author":"D Chakroborty","year":"2009","unstructured":"Chakroborty, D., Sarkar, C., Basu, B., Dasgupta, P. S., & Basu, S. (2009). Catecholamines regulate tumor angiogenesis. Cancer Research,69(9), 3727\u20133730.","journal-title":"Cancer Research"},{"issue":"43","key":"1694_CR7","doi-asserted-by":"crossref","first-page":"29341","DOI":"10.1074\/jbc.M802477200","volume":"283","author":"WI Choi","year":"2008","unstructured":"Choi, W. I., Jeon, B. N., Park, H., Yoo, J. Y., Kim, Y. S., Koh, D. I., et al. (2008). Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN). Journal of Biological Chemistry,283(43), 29341\u201329354.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"1694_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.28347","volume":"134","author":"S De Vogel","year":"2014","unstructured":"De Vogel, S., Ulvik, A., Meyer, K., Ueland, P. M., Nyg\u00e5rd, O., Vollset, S. E., et al. (2014). Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer: A large nested case\u2013control study within the JANUS cohort in Norway. International Journal of Cancer,134(1), 197\u2013206.","journal-title":"International Journal of Cancer"},{"key":"1694_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fonc.2017.00131","volume":"7","author":"E Eidelman","year":"2017","unstructured":"Eidelman, E., Twum-Ampofo, J., Ansari, J., & Siddiqui, M. M. (2017). The metabolic phenotype of prostate cancer. Frontiers in Oncology,7, 131.","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"1694_CR10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","volume":"29","author":"JI Epstein","year":"2005","unstructured":"Epstein, J. I., Allsbrook, W. C., Jr., Amin, M. B., Egevad, L. L., & ISUP Grading Committee. (2005). The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. The American Journal of Surgical Pathology,29(9), 1228\u20131242.","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"1694_CR11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcb.10724","volume":"91","author":"MR Freeman","year":"2004","unstructured":"Freeman, M. R., & Solomon, K. R. (2004). Cholesterol and prostate cancer. Journal of Cellular Biochemistry,91(1), 54\u201369.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"1694_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo9030048","volume":"9","author":"N G\u00f3mez-Cebri\u00e1n","year":"2019","unstructured":"G\u00f3mez-Cebri\u00e1n, N., Rojas-Benedicto, A., Albors-Vaquer, A., L\u00f3pez-Guerrero, J. A., Pineda-Lucena, A., & Puchades-Carrasco, L. (2019). Metabolomics contributions to the discovery of prostate cancer biomarkers. Metabolites,9(3), 48.","journal-title":"Metabolites"},{"issue":"1","key":"1694_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-016-0161-9","volume":"4","author":"RS Kelly","year":"2016","unstructured":"Kelly, R. S., Sinnott, J. A., Rider, J. R., Ebot, E. M., Gerke, T., Bowden, M., et al. (2016b). The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: Results from a nested case-control study. Cancer & metabolism,4(1), 22.","journal-title":"Cancer & metabolism"},{"issue":"6","key":"1694_CR14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/1055-9965.EPI-15-1223","volume":"25","author":"RS Kelly","year":"2016","unstructured":"Kelly, R. S., Vander Heiden, M. G., Giovannucci, E., & Mucci, L. A. (2016a). Metabolomic biomarkers of prostate cancer: Prediction, diagnosis, progression, prognosis, and recurrence. Cancer Epidemiology and Prevention Biomarkers,25(6), 887\u2013906.","journal-title":"Cancer Epidemiology and Prevention Biomarkers"},{"key":"1694_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2019.00059","volume":"10","author":"E Krashin","year":"2019","unstructured":"Krashin, E., Piekie\u0142ko-Witkowska, A., Ellis, M., & Ashur-Fabian, O. (2019). Thyroid hormones and cancer: A comprehensive review of preclinical and clinical studies. Frontiers in Endocrinology,10, 59.","journal-title":"Frontiers in Endocrinology"},{"issue":"7","key":"1694_CR17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3945\/jn.112.159319","volume":"142","author":"D Krupp","year":"2012","unstructured":"Krupp, D., Doberstein, N., Shi, L., & Remer, T. (2012). Hippuric acid in 24-hour urine collections is a potential biomarker for fruit and vegetable consumption in healthy children and adolescents. The Journal of Nutrition,142(7), 1314\u20131320.","journal-title":"The Journal of Nutrition"},{"issue":"3","key":"1694_CR18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/pr5011108","volume":"14","author":"D Kumar","year":"2015","unstructured":"Kumar, D., Gupta, A., Mandhani, A., & Sankhwar, S. N. (2015). Metabolomics-derived prostate cancer biomarkers: Fact or fiction? Journal of Proteome Research,14(3), 1455\u20131464.","journal-title":"Journal of Proteome Research"},{"issue":"12","key":"1694_CR19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/pros.23198","volume":"76","author":"D Kumar","year":"2016","unstructured":"Kumar, D., Gupta, A., Mandhani, A., & Sankhwar, S. N. (2016). NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics. The Prostate,76(12), 1106\u20131119.","journal-title":"The Prostate"},{"key":"1694_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S16747","volume":"4","author":"MF Leitzmann","year":"2012","unstructured":"Leitzmann, M. F., & Rohrmann, S. (2012). Risk factors for the onset of prostatic cancer: Age, location, and behavioral correlates. Clinical epidemiology,4, 1\u201311.","journal-title":"Clinical epidemiology"},{"issue":"8","key":"1694_CR21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale, J. W. (2013). Serine, glycine and one-carbon units: Cancer metabolism in full circle. Nature Reviews Cancer,13(8), 572.","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"1694_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11306-009-0187-x","volume":"6","author":"PG Lokhov","year":"2010","unstructured":"Lokhov, P. G., Dashtiev, M. I., Moshkovskii, S. A., & Archakov, A. I. (2010). Metabolite profiling of blood plasma of patients with prostate cancer. Metabolomics,6(1), 156\u2013163.","journal-title":"Metabolomics"},{"issue":"6","key":"1694_CR25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/fon.13.50","volume":"9","author":"G Lucarelli","year":"2013","unstructured":"Lucarelli, G., Ditonno, P., Bettocchi, C., Spilotros, M., Rutigliano, M., Vavallo, A., et al. (2013b). Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. Future Oncology,9(6), 899\u2013907.","journal-title":"Future Oncology"},{"issue":"15","key":"1694_CR23","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/pros.22514","volume":"72","author":"G Lucarelli","year":"2012","unstructured":"Lucarelli, G., Fanelli, M., Larocca, A. M. V., Germinario, C. A., Rutigliano, M., Vavallo, A., et al. (2012). Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng\/ml. The Prostate,72(15), 1611\u20131621.","journal-title":"The Prostate"},{"issue":"5","key":"1694_CR26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/14737159.2019.1604223","volume":"19","author":"G Lucarelli","year":"2019","unstructured":"Lucarelli, G., Loizzo, D., Ferro, M., Rutigliano, M., Vartolomei, M. D., Cantiello, F., et al. (2019). Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: An update. Expert Review of Molecular Diagnostics,19(5), 377\u2013387.","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"6","key":"1694_CR24","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.juro.2013.05.004","volume":"190","author":"G Lucarelli","year":"2013","unstructured":"Lucarelli, G., Rutigliano, M., Bettocchi, C., Palazzo, S., Vavallo, A., Galleggiante, V., et al. (2013a). Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer. The Journal of Urology,190(6), 2271\u20132277.","journal-title":"The Journal of Urology"},{"issue":"11","key":"1694_CR27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrc1739","volume":"5","author":"JA Ludwig","year":"2005","unstructured":"Ludwig, J. A., & Weinstein, J. N. (2005). Biomarkers in cancer staging, prognosis and treatment selection. Nature Reviews Cancer,5(11), 845\u2013856.","journal-title":"Nature Reviews Cancer"},{"key":"1694_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmaa008","author":"PA Markin","year":"2020","unstructured":"Markin, P. A., Brito, A., Moskaleva, N., et al. (2020). Plasma sarcosine measured by gas chromatography-mass spectrometry distinguishes prostatic intraepithelial neoplasia and prostate cancer from benign prostate hyperplasia. Laboratory Medicine. https:\/\/doi.org\/10.1093\/labmed\/lmaa008.","journal-title":"Laboratory Medicine"},{"issue":"9","key":"1694_CR29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2174\/0929867013372616","volume":"8","author":"A Mart\u00ednez","year":"2001","unstructured":"Mart\u00ednez, A., Knappskog, P. M., & Haavik, J. A. (2001). Structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis. Current Medicinal Chemistry,8(9), 1077\u20131091.","journal-title":"Current Medicinal Chemistry"},{"key":"1694_CR30","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1021\/acs.analchem.6b02325","volume":"88","author":"\u00d8 Midttun","year":"2016","unstructured":"Midttun, \u00d8., McCann, A., Aarseth, O., et al. (2016). Combined measurement of 6 fat-soluble vitamins and 26 water-soluble functional vitamin markers and amino acids in 50 \u03bcl of serum or plasma by high-throughput mass spectrometry. Analytical Chemistry,88, 10427\u201310436.","journal-title":"Analytical Chemistry"},{"issue":"9","key":"1694_CR31","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/ijc.29576","volume":"137","author":"AM Mondul","year":"2015","unstructured":"Mondul, A. M., Moore, S. C., Weinstein, S. J., Karoly, E. D., Sampson, J. N., & Albanes, D. (2015). Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocopherol, beta-carotene cancer prevention (ATBC) study. International Journal of Cancer,137(9), 2124\u20132132.","journal-title":"International Journal of Cancer"},{"issue":"1","key":"1694_CR32","doi-asserted-by":"crossref","first-page":"e30062","DOI":"10.1371\/journal.pone.0030062","volume":"7","author":"EA Mostaghel","year":"2012","unstructured":"Mostaghel, E. A., Solomon, K. R., Pelton, K., Freeman, M. R., & Montgomery, R. B. (2012). Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors. PLoS ONE,7(1), e30062.","journal-title":"PLoS ONE"},{"issue":"5","key":"1694_CR33","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.juro.2007.12.037","volume":"179","author":"MI Patel","year":"2008","unstructured":"Patel, M. I., Kurek, C., & Dong, Q. (2008). The arachidonic acid pathway and its role in prostate cancer development and progression. The Journal of Urology,179(5), 1668\u20131675.","journal-title":"The Journal of Urology"},{"issue":"5","key":"1694_CR34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11306-017-1194-y","volume":"13","author":"C P\u00e9rez-Rambla","year":"2017","unstructured":"P\u00e9rez-Rambla, C., Puchades-Carrasco, L., Garc\u00eda-Flores, M., Rubio-Briones, J., L\u00f3pez-Guerrero, J. A., & Pineda-Lucena, A. (2017). Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia. Metabolomics,13(5), 52.","journal-title":"Metabolomics"},{"issue":"9","key":"1694_CR35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11306-018-1413-1","volume":"14","author":"K Shestakova","year":"2018","unstructured":"Shestakova, K., Brito, A., Mesonzhnik, N. V., Moskaleva, N. E., Kurynina, K. O., Grestskaya, N. M., et al. (2018). Rabbit plasma metabolomic analysis of Nitroproston\u00ae: A multi target natural prostaglandin based-drug. Metabolomics,14(9), 112.","journal-title":"Metabolomics"},{"issue":"4","key":"1694_CR36","first-page":"203","volume":"19","author":"AM \u0160imundi\u0107","year":"2009","unstructured":"\u0160imundi\u0107, A. M. (2009). Measures of diagnostic accuracy: Basic definitions. EJIFCC,19(4), 203\u2013211.","journal-title":"EJIFCC"},{"issue":"6","key":"1694_CR37","first-page":"357","volume":"60","author":"S Slatkoff","year":"2011","unstructured":"Slatkoff, S., Gamboa, S., Zolotor, A. J., Mounsey, A. L., & Jones, K. (2011). PSA testing: When it\u2019s useful, when it\u2019s not. The Journal of Family Practice,60(6), 357\u2013360.","journal-title":"The Journal of Family Practice"},{"issue":"7","key":"1694_CR38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10585-010-9340-1","volume":"27","author":"A Soto-Guzman","year":"2010","unstructured":"Soto-Guzman, A., Navarro-Tito, N., Castro-Sanchez, L., Martinez-Orozco, R., & Salazar, E. P. (2010). Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clinical & Experimental Metastasis,27(7), 505\u2013515.","journal-title":"Clinical & Experimental Metastasis"},{"issue":"2","key":"1694_CR39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G. (2009). Clinical applications of metabolomics in oncology: A review. Clinical Cancer Research,15(2), 431\u2013440.","journal-title":"Clinical Cancer Research"},{"issue":"7231","key":"1694_CR40","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature,457(7231), 910.","journal-title":"Nature"},{"issue":"8","key":"1694_CR41","doi-asserted-by":"crossref","first-page":"e22486","DOI":"10.1371\/journal.pone.0022486","volume":"6","author":"S Stabler","year":"2011","unstructured":"Stabler, S., Koyama, T., Zhao, Z., Martinez-Ferrer, M., Allen, R. H., Luka, Z., et al. (2011). Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS ONE,6(8), e22486.","journal-title":"PLoS ONE"},{"key":"1694_CR42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpba.2014.04.022","volume":"101","author":"W Struck-Lewicka","year":"2014","unstructured":"Struck-Lewicka, W., Kaliszan, R., & Markuszewski, M. J. (2014). Analysis of urinary nucleosides as potential cancer markers determined using LC\u2013MS technique. Journal of Pharmaceutical and Biomedical Analysis,101, 50\u201357.","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"1694_CR45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pone.0014175","volume":"5","author":"E Thysell","year":"2010","unstructured":"Thysell, E., Surowiec, I., H\u00f6rnberg, E., Crnalic, S., Widmark, A., Johansson, A. I., et al. (2010). Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS ONE,5, 12.","journal-title":"PLoS ONE"},{"key":"1694_CR46","unstructured":"US Department of Health and Human Services. (2001). Bioanalytical method validation, guidance for industry. https:\/\/www.fda.gov\/cder\/guidance\/4252fnl.htm."},{"issue":"3","key":"1694_CR47","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1159\/000485242","volume":"10","author":"JC van der Mijn","year":"2017","unstructured":"van der Mijn, J. C., Kuiper, M. J., Siegert, C. E., Wassenaar, A. E., van Noesel, C. J., & Ogilvie, A. C. (2017). Lactic acidosis in prostate cancer: Consider the Warburg effect. Case Reports in Oncology,10(3), 1085\u20131091.","journal-title":"Case Reports in Oncology"},{"key":"1694_CR48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/pcan.2017.5","volume":"20","author":"AB Weiner","year":"2017","unstructured":"Weiner, A. B., Matulewicz, R. S., Eggener, S. E., & Schaeffer, E. M. (2017). Increasing incidence of metastatic prostate cancer in the United States (2004\u20132013). Prostate Cancer and Prostatic Diseases,20, 283\u2013288.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"1694_CR49","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1373\/clinchem.2005.053835","volume":"51","author":"A Windelberg","year":"2005","unstructured":"Windelberg, A., \u00c5rseth, O., Kvalheim, G., & Uealand, P. (2005). Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clinical Chemistry,51, 2103\u20132109.","journal-title":"Clinical Chemistry"},{"issue":"2","key":"1694_CR50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00216-011-5098-9","volume":"401","author":"H Wu","year":"2011","unstructured":"Wu, H., Liu, T., Ma, C., Xue, R., Deng, C., Zeng, H., et al. (2011). GC\/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization. Analytical and Bioanalytical Chemistry,401(2), 635\u2013646.","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"4","key":"1694_CR51","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ijo.2012.1588","volume":"41","author":"P Yang","year":"2012","unstructured":"Yang, P., Cartwright, C. A., Li, J. I., Wen, S., Prokhorova, I. N., Shureiqi, I., et al. (2012). Arachidonic acid metabolism in human prostate cancer. International Journal of Oncology,41(4), 1495\u20131503.","journal-title":"International Journal of Oncology"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-020-01694-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-020-01694-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-020-01694-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T23:52:07Z","timestamp":1623887527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-020-01694-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s11306-020-01694-y","relation":{},"ISSN":["1573-3882","1573-3890"],"issn-type":[{"value":"1573-3882","type":"print"},{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have a conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was approved by the Ethics Committee at the I.M Sechenov First Moscow State Medical University, Moscow, Russia. Written signed informed consent was obtained from each volunteer before entry into the study. The study was performed in conformity with the ethical principles for medical research involving humans stated in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"74"}}